Significance Statement
Although transfer RNAs (tRNAs) are best known as adapter molecules essential for translation, recent biochemical and computational evidence has led to a previously unexpected conceptual consensus that tRNAs are not always end products but can further serve as a source of small functional RNAs. Here we report that a novel type of tRNA-derived small RNA, termed SHOT-RNAs, are specifically and abundantly expressed in sex hormone-dependent breast and prostate cancers. SHOT-RNAs are produced from aminoacylated mature tRNAs by angiogenin-mediated cleavage of the anticodon loop, which is promoted by sex hormones and their receptors. We identified the complete repertoire of SHOT-RNAs, and also found their functional significance in cell proliferation. These results have unveiled a novel tRNA-engaged pathway in tumorigenesis.
Introduction
Transfer RNAs (tRNAs) are universally expressed in all three domains of life, and play a central role in protein synthesis as an adapter molecule translating codon triplet sequences into amino acids. Mature tRNAs are 70-90-nucleotide (nt) non-coding RNA molecules forming a cloverleaf secondary structure that further folds into an L-shaped tertiary structure. The human nuclear genome encodes over 500 tRNA genes (1) along with numerous genes of tRNAlookalikes resembling nuclear and mitochondrial tRNAs (2) . The multiple encoded sites and high stability place tRNAs among the most abundant RNA molecules in the cellular transcriptome. The abundance of tRNAs varies among different cell and tissue types, and altered tRNA abundance and heterogeneity have been implicated in gene expression regulation and diseases (2) (3) (4) (5) .
Although tRNAs are best known as adapter molecules essential for translation, recent experimental and computational evidence has led to a previously unexpected conceptual consensus that tRNAs are not always end products but can further serve as a source of small functional RNAs. In many organisms, small RNAs are produced from mature tRNAs or their precursor transcripts not as random degradation products, but as functional molecules involved in many biological processes beyond translation (6) (7) (8) . According to the proposed nomenclature (7), tRNA-derived small RNAs identified to date can be classified into two groups: tRNA halves and tRNA-derived fragments (tRFs). tRNA halves are composed of 30-35-nt fragments derived from either the 5′-(5′-tRNA half) or 3′-part (3′-tRNA half) of mature tRNAs. Shorter than tRNA halves, tRFs range from 13-24 nt in length and are derived from 5′-or 3′-parts of mature tRNAs, or 5′-leader or 3′-trailer sequences of precursor tRNAs (pre-tRNAs).
The expressions of eukaryotic tRNA halves were shown to be triggered by a variety of stress stimuli such as oxidative stress, heat/cold shock, and UV irradiation (9) . Therefore, tRNA halves are also known as tRNA-derived stress-induced RNAs (tiRNAs) (10) , although they are also detected under non-stressed conditions (8, 11) . In mammalian cells, the angiogenin (ANG), a member of the RNase A superfamily, was found to be the enzyme that cleaves the anticodon loops of mature tRNAs to produce the tiRNAs (10, 12) . Ribonuclease/angiogenin inhibitor 1 (RNH1), an ANG inhibitor, was shown to be a negative regulatory factor for ANG cleavage (10) . As other regulatory factors, DNA methyltransferase 2 (Dnmt2) and NOP2/Sun RNA methyltransferase 2 (NSun2) modify many tRNAs to generate the 5-methylcytidine (m 5 C) modification, which protects tRNAs from stress-induced cleavage (13, 14) .
Importantly, stress stimuli accumulate the tRNA halves not as non-functional degradation by-products but as functional molecules. Stress-induced 5′-tRNA halves promote the formation of stress granules (15) and also inhibit global translation by displacing translational initiation factor complexes from mRNAs (10, 16) . Y-box-binding protein 1 (YB-1), a multifunctional DNA/RNA-binding protein, associates with 5′-tRNA halves and mediate translational inhibition and stress granule formation (16) . A unique G-quadruplex structure of a 5′-tRNA half is crucial for translation inhibition by binding to YB-1 (17) . Supporting important roles of tRNA halves in pathogenesis, the accumulation of tRNA halves triggers cellular stress responses and apoptosis in NSun2-mutated fibroblasts of patients from neurodevelopmental disorders or Nsun2-deficient mice (14) .
Although an increasing number of reports have revealed that tRNA-derived small RNAs are involved in various biological processes beyond translation, information regarding their expression profiles is fragmented and the molecular basis behind their biogenesis and function remain elusive. Here we report a novel type of tRNA halves that are specifically and abundantly expressed in sex hormone-dependent breast and prostate cancers; these are produced by ANGcleavage of fully aminoacylated mature tRNAs, which are dependent on the presence of sex hormones and their receptors. The complete repertoire of the tRNA halves was determined by developing a method that is able to exclusively amplify and sequence tRNA halves.
Furthermore, the tRNA halves have significant functional involvement in cell proliferation, strongly suggesting that our study has unveiled a novel pathway that engages tRNA halves in the development and growth of sex hormone-dependent cancers.
Results

tRNA halves are constitutively expressed in BmN4 cells
In the course of investigating PIWI-interacting RNAs (piRNAs), a germline-specific class of small regulatory RNAs (18) (Fig. 1B) . In addition to the presence of the 5′-tRNA AspGUC half, expression of a 3′-half comprising np 35-76 of the tRNA AspGUC was also detected and identified by Northern blot and RACE analyses (Fig. 1A, 1B) .
Exploration of the expression of tRNA halves from other randomly-chosen Bombyx cytoplasmic tRNAs led to the detection of both the 5′-and 3′-halves derived from tRNA HisGUG (Fig. 1C) showed the expression of tRNA halves. These results imply that the observed expression of tRNA halves was a constitutive rather than a stress-induced phenomenon as with tiRNA expression.
5′-tRNA halves contain a phosphate at the 5′-end and a 2′,3′-cyclic phosphate at the 3′-end
To analyze terminal structure of the 5′-tRNA halves, total RNA from BT-474 cells was treated with T4 polynucleotide kinase (T4 PNK) or bovine alkaline phosphatase (BAP), and then the mobility of the bands of 5′-tRNA halves in Northern blots was examined. T4 PNK treatment removes both a phosphate and a 2′,3′-cyclic phosphate from the 3′-end of RNAs, while BAP removes a phosphate from both the 5′-and 3′-ends of RNAs. Although BAP treatment alone cannot remove a cyclic phosphate from the 3′-end of RNAs, a combination treatment of acid and BAP can remove a cyclic phosphate, because the acid converts the cyclic phosphate to a phosphate. As shown in Fig. 2B , the bands of the 5′-tRNA halves were shifted up by BAP treatment, suggesting the presence of a phosphate in the 5′-tRNA halves. T4 PNK treatment similarly shifted the bands up, and further up-shifts were observed by the acid plus BAP treatments, indicating the additional presence of a 2′,3′-cyclic phosphate in the 5′-tRNA halves. These results indicate that 5′-tRNA halves contain a phosphate at the 5′-end and a 2′,3′-cyclic phosphate at the 3′-end.
3′-tRNA halves contain a hydroxyl group at the 5′-end and an amino acid at the 3′-end
To analyze the terminal structures of the 3′-tRNA halves, BT-474 total RNA was subjected to deacylation treatment for removal of amino acids from aminoacylated tRNAs, followed by sodium periodate oxidation and -elimination, which reacts with 3′-hydroxyl end and removes the 3′-terminal nucleotide. As shown in Fig. 2C , -eliminated 3′-tRNA halves migrated faster than unreacted RNAs only after the RNAs were subjected to deacylation treatment. In other words, without deacylation treatment, -elimination was unable to react with the 3′-end of the 3′-tRNA halves due to the presence of an amino acid. These results strongly suggest that 3′-tRNA halves are fully aminoacylated at the 3′-end. For the 5′-end of the 3′-tRNA halves, BAP treatment did not influence band positions, while T4 PNK treatment with ATP was able to phosphorylate the 5′-end, resulting in up-shifting of the bands (Fig. 2C) . These results indicate the absence of a phosphate at the 5′-end. Taken together, 3′-tRNA halves contain a hydroxyl group at the 5′-end and an amino acid at the 3′-end.
Angiogenin produces the tRNA halves in breast cancer cells
In mammalian cells, angiogenin (ANG) cleaves the anticodon loops of tRNAs upon stress stimuli to produce tiRNAs (10, 12) . To determine whether ANG is required for the production of tRNA halves in breast cancer, we performed RNAi knockdown of ANG expression in BT-474 cells. Both of the two different siRNAs designed to target the ANG gene were effective to decrease ANG mRNA levels to around 40% compared with control siRNAs (Fig. S6A) . Strikingly, transfection with each of the ANG-targeting siRNAs commonly resulted in the reduction of tRNA halves from tRNA AspGUC (Fig. S6B ) and tRNA HisGUG (Fig. 2D) , while the levels of corresponding mature tRNAs and control miR-16 did not change. These results strongly suggest that the ANG catalyzes the anticodon cleavage of mature tRNAs to produce tRNA halves in breast cancer cells (Fig. 2E) .
Quantification of SHOT-RNAs by TaqMan qRT-PCR
Because there was a clear difference in the abundance of tRNA halves between the breast cancer cell lines and HeLa ( Fig. 2A) to exclusively quantify 5′-or 3′-tRNA halves (Fig. 3A, 3B ). Total RNA was first treated with T4 PNK and ATP to dephosphorylate the 3′-end of the 5′-tRNA halves, and at the same time to phosphorylate the 5′-end of the 3′-tRNA halves. Subsequently, a 3′-or 5′-RNA adapter was ligated to the 5′-or 3′-tRNA halves, respectively, followed by quantification of the ligation products by TaqMan qRT-PCR. The method successfully amplified and quantified the 5′-tRNA AspGUC half, 5′-tRNA HisGUG half (Fig. 3A) , and 3′-tRNA AspGUC half (Fig. 3B) , while no signal was detected from attempted amplification of the 3′-tRNA HisGUG half, which was most likely because np 37 m 1 G hindered reverse transcription. Because the TaqMan probes were designed to target the boundary of the tRNA halves and RNA adapters, only adapter-ligated tRNA halves, but not mature tRNAs and pre-tRNAs, were specifically quantified by this method. Indeed, a method without an RNA ligation step failed to produce detectable signals, and a method without T4 PNK treatment severely reduced the signals (Fig. 3A, 3B ). The abundance of tRNA halves was much greater in BT-474 than in HeLa cells, which is consistent with the Northern blot results (Fig. 2A) ; this confirmed the credibility of the method.
Abundant accumulation of tRNA halves in specific breast and prostate cancer cell lines
With this novel method, the expression of the three tRNA halves was profiled in 94 cell lines from liver, pancreas, stomach, colon, esophagus, oral, lung, breast, and prostate cancers as well as in non-cancerous breast epithelial MCF10A cells (Fig. 3C) (Fig. 3D) . These results confirm the effectiveness of our screening method, and the particularly abundant expression of tRNA halves in specific breast and prostate cancer cell lines.
Expression of tRNA halves is dependent on sex hormones and their receptors
What are the molecular factors regulating the expression levels of the tRNA halves?
Notably, the expression levels of mature tRNA AspGUC and tRNA HisGUG , as determined by
Northern blots ( Fig. 2A, 3D ), were not particularly high in the MCF-7, BT-474, or LNCaP- halves, while AR-negative DU145 and PC-3 cells commonly had low levels of tRNA halves ( Fig. 3C, 3D ). These correlations allowed us to hypothesize that sex hormone sensitivity and hormone receptor expression could be a driving force to trigger and regulate the production of tRNA halves in breast and prostate cancers.
To test our hypothesis, we performed RNAi knockdown of ER expression in MCF-7
and BT-474 breast cancer cells and of AR expression in LNCaP-FGC prostate cancer cells.
siRNAs targeting ER or AR successfully decreased levels of the target mRNA below 25%, while there was no effect on HER2 mRNA (Fig. 4A) . Strikingly, in the all three cell lines, ER or AR knockdowns commonly reduced the amounts of 5′-tRNA AspGUC half and 5′-tRNA HisGUG half ( Fig. 4A) . To further confirm our hypothesis, we cultured the three cell lines with hormonefree medium as an alternative method to create hormone-insensitive states. As shown in Fig.   4B , the amounts of tRNA halves were decreased in all three cell lines cultured in hormone-free medium. Moreover, we added the corresponding sex hormones, estradiol and DHT, to the medium culturing MCF-7 and BT-474 breast cancer cells and LNCaP-FGC prostate cancer cells, respectively, and observed that the addition of the hormones commonly increased the levels of tRNA halves in all three cell lines (Fig. 4C) . These results clearly indicate the dependency of tRNA half expressions on sex hormones and their receptors. Therefore, we termed this novel type of tRNA halves as Sex HOrmone-dependent TRNA-derived RNAs (SHOT-RNAs). Hereafter, we will use 5′-or 3′-SHOT-RNA amino acid/anticodon sequence to denote SHOT-RNA derived from 5′-or 3′-halves of the tRNA.
Both ER and AR act as transcription factors to regulate the transcription of many target genes upon binding of corresponding hormones (27, 28) . However, mRNA expression levels of both ANG and RNH1 in LNCaP-FGC cells were not changed when cultured in hormonefree medium (Fig. S7A) , indicating that SHOT-RNA expression is not triggered by the direct regulation of ANG and RNH1 transcription by hormone receptors. In addition, we observed that RNH1 protein levels were unchanged after culturing in hormone-free medium (Fig. S7B) .
These results suggest that SHOT-RNA generation may not be regulated by RNH1, in contrast to the case of tiRNAs where the quantitative changes in RNH1 regulate expression (29) .
Development of cP-RNA-seq method to specifically identify cyclic phosphate-containing
RNA species
Next, we aimed to clarify the tRNA species that generate SHOT-RNAs. 5′-and 3′-SHOT-RNAs contain the 3′-terminal modifications, a 2′,3′-cyclic phosphate and an amino acid (Fig. 2B, 2C ), which would inhibit the adapter ligation step included in RNA sequencing methods. Therefore, RNA sequencing methods without procedures to remove such 3′-modifications cannot accurately capture SHOT-RNA expressions. To identify a comprehensive repertoire of 5′-SHOT-RNAs, we developed a method termed "cP-RNA-seq" that is able to exclusively amplify and sequence RNAs containing a 3′-terminal cyclic phosphate (Fig. 5A ).
In the cP-RNA-seq targeting 5′-SHOT-RNAs, 30-50-nt RNAs were first gel-purified from total RNA. Then, phosphatase treatment was used to remove a phosphate from both the 5′-and 3′-ends of the gel-purified RNAs, although the state of cyclic phosphate was not changed.
Eventually, the RNA pools mainly contained two RNA subgroups, one with both 5′-and 3′-hydroxyl ends, and a second with 5′-hydroxyl and 3′-cyclic phosphate ends. Subsequent periodate treatment cleaved the cis-diol group of the 3′-hydroxyl end of the former group to generate 2′,3′-dialdehydes that no longer serve as a substrate for adapter ligation. The latter group survived periodate treatment because of the presence of a 3′-cyclic-phosphate. Therefore, after removal of cyclic phosphate by kinase treatment, the latter group became the only RNA group that bears a 3′-hydroxyl end for 3′-adapter ligation. Subsequent 5′-adapter ligation, RT-PCR amplification, and next-generation sequencing of the cDNAs thus exclusively identified the sequences of 3′-cyclic phosphate-containing RNAs.
Identification of a comprehensive repertoire of SHOT-RNAs
To capture 5′-SHOT-RNAs, we applied the cP-RNA-seq method to total RNA isolated from BT-474 breast cancer cells. The method successfully amplified ~153-bp bands (considering adapters' lengths, inserted RNAs were estimated to be ~35 nt) (Fig. 5B ) whose dependency on T4 PNK treatment suggests that as expected the amplified bands were derived from cyclic-phosphate-containing RNAs. Consistent with the low levels of 5′-tRNA halves in HeLa cells detected by Northern blots ( Fig. 2A) , this method failed to yield clear bands from
HeLa total RNA (Fig. 5B) . Illumina sequencing of the amplified bands from BT-474 cells yielded approximately 33 million reads that aligned to the human genome, of which around 28 million reads (~85%) were mapped to tRNAs. Among the tRNA mapped reads, we focused the RNA species with >10,000 reads that in aggregate accounted for >98.9% of the reads. Of these, almost all sequences were unanimously derived from 5′-halves of mature tRNAs with lengths of 32-35 nt ( Fig. 5C and 5D ), which validated the use of the cP-RNA-seq method to capture the repertoire of 5′-SHOT-RNAs.
Only eight cytoplasmic tRNA species were identified to be a source of 5′-SHOT-RNAs with >0.1% reads of the 5′-tRNA half sequences identified by cP-RNA-seq (Fig. 5D) . 5′-SHOT-RNA LysCUU and 5′-SHOT-RNA HisGUG were particularly enriched, which comprised 60.4% and 27.5% of the total reads, respectively. As with Northern blot (Fig. 2) and qRT-PCR analyses (Fig. 3, 4) , 5′-SHOT-RNA AspGUC was also detected by cP-RNA-seq. The majority of the 5′-SHOT-RNAs were derived from a region that started at np 1 (5′-end) and ended at np 32-34 in the anticodon loop of the mature tRNAs (Fig. 5E) . The sequence results of 5′-SHOT-RNA AspGUC and 5′-SHOT-RNA HisGUG were consistent with RACE results (Fig. S4B) . The identified 3′-terminal position of the 5′-SHOT-RNAs exhibited focal patterns of ANG cleavage (Fig. 5F) . As the RNase A superfamily has been reported to share substrate preferences for a pyrimidine (30, 31), major sites for ANG cleavage within the anticodon loop were located between cytidine and uridine or guanosine and uridine residues, implying that ANG tends to cleave the 5′-side of uridines in the anticodon loop.
5′-SHOT-RNAs enhance cell proliferation
Because the expression of tRNA halves was correlated to cell proliferation in BmN4 cells (Fig. 1C) , we hypothesized that SHOT-RNAs are not just non-functionally accumulated but 6A ) and Northern blots (Fig. S8) , we confirmed that the siRNA transfection specifically reduced the levels of 5′-SHOT-RNA LysCUU . Upon 5′-SHOT-RNA LysCUU reduction, strikingly, the cell growth rate was decreased compared with control siRNA-transfected cells (Fig. 6B) .
Because the levels of mature tRNA were not changed by siRNA transfection (Fig. 6A, Fig. S8 SHOT-RNAs are generated by ANG cleavage of the anticodon loop of aminoacylated cytoplasmic tRNAs, resulting in the accumulation of 5′-SHOT-RNAs containing a phosphate at the 5′-end and a 2′,3′-cyclic phosphate at the 3′-end, and of 3′-SHOT-RNAs containing a 5′-hydroxyl group at the 5′-end and an amino acid at the 3′-end. It is notable that ANG leaves a cyclic phosphate, while bovine pancreatic RNase A, the best-studied ribonuclease, leaves a phosphate by way of an intermediate cyclic phosphate state (38) . The presence of a 3′-terminal cyclic phosphate and amino acid in SHOT-RNAs suggest that the SHOT-RNAs will not be accurately captured by normal RNA sequencing methods because the 3′-terminal modifications hinder the adapter ligation steps. To fully sequence SHOT-RNAs by RNA-seq, total RNA should be subjected to deacylation and T4 PNK treatment in advance to remove the 3′-terminal cyclic phosphate and amino acid.
By devising the cP-RNA-seq method, we succeeded in exclusively amplifying and identifying the complete 5′-SHOT-RNAs repertoire. Only specific tRNAs become a source for SHOT-RNAs. The members of the RNase A superfamily shares a substrate preference for a pyrimidine, such that ANG has been reported to cleave the 5′-side of cytidine and uridine (30) .
In the case of SHOT-RNA production, ANG cleavage mainly occurs between cytidine/guanosine and uridines. However, because many non-cleaved cytoplasmic tRNAs also contain cytidine and uridine in their anticodon loops, the sequence preference of ANG may not be the sole reason for the selective production of SHOT-RNAs from specific tRNA sources. It is noteworthy that more than 96% of the SHOT-RNA sequence reads were derived from the tRNAs with corresponding amino acids that were positively-or negatively-charged, such as lysine, histidine, glutamate, and aspartate. Considering that SHOT-RNAs are produced from fully-aminoacylated mature tRNAs, the properties of amino acid species may be involved in (Fig. 7B) . In addition, as a non-canonical pathway, extracellular estrogen binds to the plasma membrane ERs, which initiates signal cascades via second messengers and leads to the activation of other TFs. In prostate cancer, testosterone is converted to DHT by 5α-reductase, and the DHT-bound ARs form dimers and bind to androgen response elements (ARE), inducing the transcription of target genes ( Fig. 7B) (27) . 
Materials and Methods
tRNA sequences
Sequences of Bombyx and human tRNAs were identified using the tRNAscan-SE program (1, 44) . As shown in Fig. S1, S3 , and S9, the tRNA sequences were sorted by mismatches and aligned using DNADynamo software (BlueTractor Software).
Cell culture
BmN4 cells were cultured as previously described (20) . To arrest the cell cycle, double 
RACE identification of terminal sequences of tRNA halves
The sequences of adapters and primers for RACE analysis are shown in Table S1 . The fraction of 30-50-nt RNAs were gel-purified from the total RNA of BmN4, HeLa, and BT-474 cells.
For 5′-RACE to analyze the 5′-terminal sequences of the 3′-tRNA AspGUC half, purified
RNAs were treated with T4 PNK (New England Biolabs) and 100 µM ATP to phosphorylate the 5′-end of the 3′-tRNA half. Then, the RNAs were subjected to a ligation reaction with a 5′-RNA adapter using T4 RNA ligase (T4 Rnl; Fisher Scientific). The ligated RNAs were subjected to RT-PCR using the One Step SYBR Ex Taq qRT-PCR Kit (Takara). For 3′-RACE to analyze the 3′-terminal sequences of 5′-tRNA halves, RNAs were treated with T4 PNK to remove the 3′-terminal cyclic phosphate of the 5′-tRNA halves. Then, the RNAs were subjected to a ligation reaction with a 3′-RNA adapter, followed by RT-PCR. The PCR products were cloned using the StrataClone PCR cloning kit (Agilent Technologies).
RNA isolation, enzymatic treatment, and β-elimination
RNA isolation, enzymatic treatment, and β-elimination were performed as previously described (20, 45) . In brief, total RNA was isolated using TRIsure reagent (Bioline). To investigate the terminal structures of SHOT-RNAs, total RNA was treated with BAP (Takara), T4 PNK (New England Biolabs, with ATP), or acid (incubation in 10 mM HCl at 4°C for 3 h).
For deacylation treatment, total RNA was incubated in 20 mM Tris-HCl (pH 9.0) at 37°C for 40 min. For β-elimination reaction, total RNA was first incubated with 10 mM NaIO4 at 0°C for 40 min in the dark. 1 M rhamnose (1/10 volume) was then added to quench unreacted NaIO4 and incubated at 0°C for 30 min. Subsequently, β-elimination was performed by adding an equal volume of 2 M Lys-HCl (pH 8.5) and incubating at 45°C for 90 min.
Northern blot
Northern blot analysis was performed as described previously (20) . The sequences of probes are shown in Table S2 . The visualization and quantification were performed with storage phosphor autoradiography using Typhoon-9400 and ImageQuant ver. 5.2 (GE Healthcare).
RNAi knockdowns of ANG
For RNAi knockdown of ANG, two siRNAs were designed using the siExplorer algorithm (46) and synthesized by Bioland Scientific LLC. The siRNA sequences are shown in Table S3 . Table S4 .
Quantification of SHOT-RNAs by TaqMan qRT-PCR
The sequences of the adapters and primers for SHOT-RNA quantification by TaqMan qRT-PCR are shown in Table S5 . To dephosphorylate the 3′-end of 5′-SHOT-RNAs, and at the same time to phosphorylate the 5′-end of 3′-SHOT-RNAs, 1 µg of total RNA was treated with T4 PNK and 100 µM ATP. For quantification of 5′-SHOT-RNAs, 100 ng of the treated RNAs were subjected to a ligation reaction (10- Table S4 .
The expression levels were normalized to GAPDH levels. As an alternative method to create hormone-insensitive state, the cells were cultured in phenol red-free medium containing 10% charcoal stripped FBS (CS-FBS; Life Technologies) for 120 h. With respect to hormone addition experiments, MCF7 and BT-474 cells were treated for 48 h with 10 nM and 100 nM of 17β-Estradiol (Sigma), respectively, and LNCaP-FGC cells were treated for 48 h with 10 nM of DHT (Sigma). RNH1 protein levels were examined by a western blot using anti-RNH1
antibody (Proteintech). -tubulin was examined as an internal control by using anti--tubulin (Developmental Studies Hybridoma Bank).
cP-RNA-seq to selectively amplify and sequence 5′-SHOT-RNAs
As shown in Fig. 5A , 35-50-nt RNAs were gel-purified from BT-474 total RNA. Then, the purified RNAs were treated by calf intestinal alkaline phosphatase (CIP; New England Biolabs). After phenol-chloroform purification, the RNAs were oxidized by incubation in 10 mM NaIO4 at 0°C for 40 min in the dark, followed by ethanol precipitation. The RNAs were then treated with T4 PNK. After phenol-chloroform purification, directional ligation of adapters, cDNA generation, and PCR amplification were performed using the Truseq Small RNA Sample Prep kit (Illumina) according to the manufacture's protocol. The amplified cDNAs were sequenced using Illumina hiSeq2000 system at the Functional Genomics Core at the University of Pennsylvania.
Bioinformatics analyses of 5′-SHOT-RNAs
The analyzed 5′-SHOT-RNA sample contains 50,220,564 raw reads and can be found publically on GEO # (accession No. will be obtained soon). Prior to mapping we used the cutadapt tool (DOI: http://dx.doi.org/10.14806/ej.17.1.200) to remove 3′-adapter sequence: 5′-TGGAATTCTCGGGTGCCAAGG-3′. We used SHRiMP2 (47) for all read mappings and did not allow for any insertions or deletions when mapping. We used a set of 632 tRNA-reference genes comprised of 610 nuclear tRNAs from the GRCh37 (hg19) human genome assembly (listed in gtRNAdb (1)) and 22 known mitochondrial tRNAs from tRNAdb (48) . The 610 entries from gtRNAdb include 508 true tRNAs and 102 psuedo-tRNAs. We purposely excluded selenocysteine tRNA, tRNAs with undetermined anticodon identity, and tRNAs mapping to contigs that are not part of the major chromosome assembly. To help validate the "cP-RNAseq" method by confirming that most of the reads landed on tRNAs and to account for the repetitive nature of tRNA sequences, we mapped the reads to the full-genome allowing a 4% mismatch rate and allowing nonunique mappings. Approximately 33 million reads mapped of which ~28 million (~85%) intersected with at least 1 of the 632 tRNA-reference genes.
RNAi knockdown of SHOT-RNAs
siRNA targeting each SHOT-RNA was designed using siExplorer (46) and synthesized by Bioland Scientific LLC. The siRNA sequences are shown in Table S3 . Table S6 . Briefly, total RNA was subjected to deacylation treatment, followed by ligation reaction with a DNA/RNA-hybrid stem-loop adapter using T4 RNA ligase 2 (New England Biolabs) that specifically ligates the adapter to mature tRNA. The ligation products were specifically amplified and quantified by TaqMan qRT-PCR.
Cell proliferation assay
LNCaP-FGC cells were transfected with the SHOT-RNA-targeted siRNAs and plated in a 96-well cell culture plate. Cell proliferation and viability were determined with AlamarBlue
Cell Viability Reagent (Life Technologies). At 24, 48, 72, 96 , and 120 h after transfection, AlamarBlue reagent was added to the medium and the cells were incubated for another 6 h.
Absorbance was measured at 570 and 600 nm and relative cell abundance was calculated using the manufacturer's instruction.
SHOT-RNA quantification using breast cancer patient FFPE samples
Total RNA was extracted from 1-3 10 m-thick FFPE sections using the RecoverAll Total Nucleic Acid Isolation Kit (Life technologies) according to the manufacturer's protocol.
A total RNA amount of 100 ng was treated with T4 PNK and 100 µM ATP, following which 50 ng of the treated RNAs were subjected to a ligation reaction (10-µL reaction mixture) with 20 pmol of a 3′-RNA adaptor using T4 Rnl. Subsequently, 500 pg of ligated RNA was subjected to TaqMan qRT-PCR as described above for SHOT-RNA detection using cell lines. 5S rRNA expression levels were quantified by SsoFast EvaGreen Supermix (BioRad) and used for normalization. (D) BmN4 cells were subjected to thymidine block treatment and total RNA from the cells was subjected to Northern blot using a 5′-probe for tRNA AspGUC . Among 5′-SHOT-RNA LysCUU reads shown in Fig 5D, 24 
